about
9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotectionA randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonancePermanent transvenous pacing after a Mustard procedure.Calibration of myocardial T2 and T1 against iron concentration.Acute effects of ketanserin on left ventricular function, metabolism and coronary blood flow.Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial.Anthracycline Chemotherapy and Cardiotoxicity.Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.Thalassaemia major and the heart: a toxic cardiomyopathy tamed?Ultrafast Magnetic Resonance Imaging for Iron Quantification in Thalassemia Participants in the Developing World: The TIC-TOC Study (Thailand and UK International Collaboration in Thalassaemia Optimising Ultrafast CMR).Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine.Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies.Remote Ischemic Conditioning Reduces Myocardial Infarct Size in STEMI Patients Treated by Thrombolysis.Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.Cardio-Oncology - A new subspecialty with collaboration at its heart.Inotropic and vasodilator effects of amrinone on isolated human tissue.Hypersensitivity vasculitis complicating intravenous streptokinase therapy in acute myocardial infarctionDobutamine thallium myocardial perfusion tomographyCongenital diverticulum of the left ventricle presenting as heart failure and diagnosed by magnetic resonance imagingRelationships between beat-to-beat interval and the strength of contraction in the healthy and diseased human heartA comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable anginaSystemic sclerosis associated with right ventricular cardiomyopathyAttenuation by heat stress of a submaximal calcium paradox in the rabbit heartAcute ischaemia: a dynamic influence on QT dispersionCerebral microembolism detected by transcranial Doppler during cardiac proceduresProlonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned stateThe heart in thalassaemiaCardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overloadNormalized left ventricular volumes and function in thalassemia major patients with normal myocardial ironLeft ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia majorMyocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathyRelation of myocardial T2* to right ventricular function in thalassaemia majorSerial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death
P50
Q26750797-EFBB9730-41D1-4890-9671-A3D54DE18DE4Q28293758-45DB1651-0A9F-48F0-B070-F4CCD7C3B5B8Q33164249-A46C4ED4-FB04-4746-922C-DA08FF71CE80Q34091560-145F4E1C-7B6C-4541-8BF3-61F66FFAEC60Q34621074-37724AC2-E8E6-42C1-B48C-DAF2BE0BDE72Q36532618-3CBA936F-4F61-4FFC-8800-D697F20190CDQ36894836-146B9924-C4A5-4481-A319-16AA0184ACF4Q37694541-0972A5AB-F4A9-4887-8742-8B552A4B75EEQ37721775-130DA69E-A547-406C-93D9-24CD26B5971DQ38061849-6C8644E9-8636-438E-AC26-DA34C725B2EDQ42392756-4492ED0D-D577-418A-9926-C5EF7CD9B5B0Q46902527-9CBE73F1-EC30-48F0-9011-AA682D5202ADQ47321470-804A0632-651E-4D60-B456-081A4F30AAF4Q47378684-D3247AB2-A61E-45B9-B270-F81DDEB1779EQ48508712-19BE8D53-E5B7-44D8-B892-34F4DA61D8EDQ53104651-37BC27E6-C18A-4A36-B31B-A4E3CA017249Q53911148-54C2EB85-8AFB-4C7B-A897-68F3DD563E6BQ68022600-12749C83-0ECB-4B07-B016-1D452A4F5149Q68042153-923FBE9C-B829-4ACB-ACCA-D677B946D630Q69182479-2A2479A1-E618-41D6-A26B-FAE10722B2C7Q70641966-85EDD897-6B95-4065-9CCB-F0E07BD48B27Q71195267-50E55627-296D-4097-B2D7-F20EBC7434BBQ71415726-3EB2C24D-0049-44C3-B31F-D23AF7FE0A39Q72712972-D57D799D-C943-4C15-8A16-FFF3205EC353Q73048053-BEE94844-218E-4591-AC0A-39F55A237F02Q73048927-F542542E-F429-447A-B416-73C34F460312Q74485280-2A6D631E-0AA6-4C14-9D44-8D8741139C9EQ77474791-75995438-006B-4C94-91E6-035E174EF52AQ77820142-E789DECC-D580-41CD-A9D2-2506D4C45C86Q80372740-35E58372-813A-4DED-8C0F-436CFCDC081AQ80390852-119C39D2-3441-4A81-B408-50624D7AB454Q80868057-E7A492C3-B980-4717-A645-060EAE6571C9Q84096663-4ECF235F-80D8-404B-BEDA-0574FB68F7BAQ85931079-D8F92799-0A33-49E6-8E0A-3BB89C572339
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
J M Walker
@ast
J M Walker
@en
J M Walker
@es
J M Walker
@nl
type
label
J M Walker
@ast
J M Walker
@en
J M Walker
@es
J M Walker
@nl
prefLabel
J M Walker
@ast
J M Walker
@en
J M Walker
@es
J M Walker
@nl
P31
P496
0000-0002-8559-7218